Biocon Ltd. — Regulatory Filings 2021

Nov 17, 2021

==> picture [102 x 40] intentionally omitted <==

Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423 CIN : L24234KA1978PLC003417

www.biocon.com

November 17, 2021

To	To
The Secretary	The Secretary
BSE Limited	National Stock Exchange of India Limited
Department of Corporate Services	Corporate Communication Department
Phiroze Jeejeebhoy Towers,	Exchange Plaza, Bandra Kurla Complex
Dalal Street,Mumbai – 400 001	Mumbai – 400 050
Scrip Code - 532523	Scrip Symbol - BIOCON

Dear Sir/Madam,

Sub: Meetings conducted with Institutional Investors/Research Analysts.

Ref: Intimation under Regulation 30 (6) of SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015.

Pursuant to Regulation 30 (6) of the SEBI LODR Regulations, 2015, we hereby inform you that the following meetings were conducted with Institutional Investor/ Research Analysts:

Date	Name	Type of meeting	Location
November 16,2021	White Oak Capital Partners	Teleconference	Bangalore
November 16,2021	Wellington Management Co. LLP	Teleconference	Bangalore
November 16,2021	GIC Pte Ltd.	Teleconference	Bangalore
November 16,2021	Ashmore Investment Management	Teleconference	Bangalore
November 16,2021	UTI Mutual Fund	Teleconference	Bangalore
November 16,2021	LGM Investments	Teleconference	Bangalore
November 16,2021	East Lane Capital	Teleconference	Bangalore

We request you to kindly take above intimation on record.

Thanking You,

Yours faithfully,

For Biocon Limited

==> picture [72 x 32] intentionally omitted <==

==> picture [73 x 76] intentionally omitted <==

---

Mayank Verma Company Secretary and Compliance Officer